Announcement awardees of the TBVI Young Scientist Award 2023-2024
To encourage talented young scientists and recognise outstanding contributions to TB vaccine research and development, in October TBVI published the TBVI Young Scientist Awards 2024. It is our pleasure to announce the three winners of the 2023-2024 award: Paul OgongoPaul grew up in Kenya where he got his bachelor’s and master’s degrees. In 2019 […]
Announcement awardees of the TBVI Young Scientist Award 2023-2024
To encourage talented young scientists and recognise outstanding contributions to TB vaccine research and development, in October TBVI published the TBVI Young Scientist Awards 2024. It is our pleasure to announce the three winners of the 2023-2024 award: Paul OgongoPaul grew up in Kenya where he got his bachelor’s and master’s degrees. In 2019 […]
Save the date – 7th Global Forum October 2024
The Working Group on New TB Vaccines (WGNV), IAVI, and the TuBerculosis Vaccine Initiative (TBVI), in partnership with the Ministry of Health of Brazil and the Brazilian TB Research Network (REDE-TB), are pleased to announce that the 7th Global Forum on TB Vaccines will be held in Rio de Janeiro, Brazil from 8 – 10 […]
Global TB Report 2023
The WHO published the Global TB Report 2023. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease. In 2022 TB-related deaths, including those among people with HIV, was 1.3 million. You can read the report here: Global TB Report 2023
Call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model
Diversification of the vaccine development pipeline has been identified as a priority area in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has been able to secure funds for a 4-year project that aims, amongst other things, to fill the early phases of the development pipeline while ensuring a diverse portfolio (https://www.tbvi.eu/projects/tbvac-horizon/). One of the […]
Save the date: TBVI Symposium Les Diablerets 2024
We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 30-31 January 2024. TB vaccine researchers, developers, funders and policymakers in TBVI’s network will gather together to be updated on the latest developments in the field and to exchange new ideas. We would be […]
TBVI Young Scientist Award 2023-2024
Would you like to present your work at the TBVI Annual Symposium? To encourage talented young scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Young Scientist Awards. Young scientists are given the opportunity to present their work during the annual TBVI symposium where researchers, policy makers and funders […]
TBVI Governance Board Communiqué
TBVI Governance Board Communiqué Tuberculosis (TB) is a major unsolved global health problem. Novel vaccines against TB will be critical tools to ultimately end this silent pandemic. TBVI and its partners are key actors in the effort to research and develop novel TB vaccines. The TuBerlculosis Vaccine Initiative (TBVI) Governance Board would like to announce […]
First progress meeting MTBVACN3
From 15-18 May 2023, the first annual progress meeting of the MTBVAC phase III clinical trial EDCTP co-funded project took place in Andasibe and Antananarivo, Madagascar. The consortium, composed of nine partners in total of which six recruiting sites (four in South Africa, one in Senegal and one in Madagascar), informally and formally discussed the […]
Start ITHEMYC
The Horizon Europe programme has funded the ITHEMYC project to establish a critical path for selection of promising innovative adjunct TB immunotherapies and progress 2 of these immunotherapies to completion of preclinical proof of concept. Read more about the project and its partners.